BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25275042)

  • 1. Lysophosphatidylserine stimulates chemotactic migration of colorectal cancer cells through GPR34 and PI3K/Akt pathway.
    Iida Y; H Tsuno N; Kishikawa J; Kaneko K; Murono K; Kawai K; Ikeda T; Ishihara S; Yamaguchi H; Sunami E; Kitayama J; Yatomi Y; Watanabe T
    Anticancer Res; 2014 Oct; 34(10):5465-72. PubMed ID: 25275042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPR34 is a receptor for lysophosphatidylserine with a fatty acid at the sn-2 position.
    Kitamura H; Makide K; Shuto A; Ikubo M; Inoue A; Suzuki K; Sato Y; Nakamura S; Otani Y; Ohwada T; Aoki J
    J Biochem; 2012 May; 151(5):511-8. PubMed ID: 22343749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-protein coupled receptor 34 regulates the proliferation and growth of LS174T cells through differential expression of PI3K subunits and PTEN.
    Zuo B; Wu N; Yang S; Zhong Z; Li M; Yu X; Liu Y; Yu W
    Mol Biol Rep; 2022 Apr; 49(4):2629-2639. PubMed ID: 34997428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPR34 as a lysophosphatidylserine receptor.
    Makide K; Aoki J
    J Biochem; 2013 Apr; 153(4):327-9. PubMed ID: 23389307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a lysophosphatidylserine receptor on mast cells.
    Sugo T; Tachimoto H; Chikatsu T; Murakami Y; Kikukawa Y; Sato S; Kikuchi K; Nagi T; Harada M; Ogi K; Ebisawa M; Mori M
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1078-87. PubMed ID: 16460680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid synthase regulates proliferation and migration of colorectal cancer cells via HER2-PI3K/Akt signaling pathway.
    Li N; Bu X; Tian X; Wu P; Yang L; Huang P
    Nutr Cancer; 2012 Aug; 64(6):864-70. PubMed ID: 22860766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidylserine analogues differentially activate three LysoPS receptors.
    Uwamizu A; Inoue A; Suzuki K; Okudaira M; Shuto A; Shinjo Y; Ishiguro J; Makide K; Ikubo M; Nakamura S; Jung S; Sayama M; Otani Y; Ohwada T; Aoki J
    J Biochem; 2015 Mar; 157(3):151-60. PubMed ID: 25320102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidylserine suppresses IL-2 production in CD4 T cells through LPS
    Shinjo Y; Makide K; Satoh K; Fukami F; Inoue A; Kano K; Otani Y; Ohwada T; Aoki J
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):332-338. PubMed ID: 29017923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of GPR34 expression affects the progression and prognosis of human gastric adenocarcinoma by PI3K/PDK1/AKT pathway.
    Yu W; Ma S; Wang L; Zuo B; Li M; Qiao Z; Pan X; Liu Y; Wang J
    Histol Histopathol; 2013 Dec; 28(12):1629-38. PubMed ID: 23836308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for ligand recognition and signaling of the lysophosphatidylserine receptors GPR34 and GPR174.
    Liu G; Li X; Wang Y; Zhang X; Gong W
    PLoS Biol; 2023 Dec; 21(12):e3002387. PubMed ID: 38048360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for lysophosphatidylserine recognition by GPR34.
    Izume T; Kawahara R; Uwamizu A; Chen L; Yaginuma S; Omi J; Kawana H; Hou F; Sano FK; Tanaka T; Kobayashi K; Okamoto HH; Kise Y; Ohwada T; Aoki J; Shihoya W; Nureki O
    Nat Commun; 2024 Feb; 15(1):902. PubMed ID: 38326347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway.
    Yousif NG
    Cell Biol Int; 2014 Jan; 38(1):85-91. PubMed ID: 24115647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
    Wang Y; Tang Q; Li M; Jiang S; Wang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular chaperone Cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK.
    Huang J; Che MI; Lin NY; Hung JS; Huang YT; Lin WC; Huang HC; Lee PH; Liang JT; Huang MC
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E62-71. PubMed ID: 23390052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways.
    Baek YY; Cho DH; Choe J; Lee H; Jeoung D; Ha KS; Won MH; Kwon YG; Kim YM
    Eur J Pharmacol; 2012 Jan; 674(2-3):188-99. PubMed ID: 22130357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
    Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-protein coupled receptor 34 knockdown impairs the proliferation and migration of HGC-27 gastric cancer cells in vitro.
    Jin ZT; Li K; Li M; Ren ZG; Wang FS; Zhu JY; Leng XS; Yu WD
    Chin Med J (Engl); 2015 Feb; 128(4):545-9. PubMed ID: 25673461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
    Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
    Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
    J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.